SMAD5 and diffuse large B-cell lymphoma: High levels of miR-155 also inactivate human germinal center-associated lymphoma (HGAL) and mothers against decapentaplegic homolog 5 (SMAD5) [26, 27], thus increasing the invasiveness of DLBCL cells and leading to a poor clinical prognosis.